Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK1 | Q15118 | 9/20 | 0.47 |
| ▸ | PDK2 | Q15119 | 9/20 | 0.47 |
| ▸ | PDK3 | Q15120 | 9/20 | 0.47 |
| ▸ | PDK4 | Q16654 | 9/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27858113 | 0.82 | ACHE (0.48) | ACHE | |
| SCHEMBL24019248 | 0.81 | SRD5A1 (0.48) | PDK1PDK2PDK3PDK4 | |
| SCHEMBL22815961 | 0.79 | PDK1 (0.50) | PDK1PDK2PDK3PDK4 | |
| SCHEMBL13162977 | 0.79 | ALDH1A1 (0.56) | PDK1PDK2PDK3PDK4HSP90AA1 | |
| Hydrochloric Acid SCHEMBL12500832 | 0.78 | ATAD2 (0.42) | — | |
| SCHEMBL20870184 | 0.78 | PDK1 (0.40) | PDK1PDK2PDK3PDK4 | |
| SCHEMBL28311915 | 0.78 | ACHE (0.42) | ACHE | |
| SCHEMBL28217685 | 0.76 | SIRT2 (0.50) | PDK1PDK2PDK3PDK4 | |
| SCHEMBL10972417 | 0.76 | ALDH1A1 (0.55) | PDK1PDK2PDK3PDK4HSP90AA1 | |
| SCHEMBL27509009 | 0.76 | ALDH1A1 (0.36) | PDK1PDK2PDK3PDK4HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0867432-B1 | Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists | AVENTIS PHARMA GMBH (DE) | 2004-06-09 | — | — | EP | disclosed |
| EP-0867432-A2 | Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-09-30 | — | — | EP | disclosed |